These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 24860095)

  • 1. Mouse models for studying the formation and propagation of prions.
    Watts JC; Prusiner SB
    J Biol Chem; 2014 Jul; 289(29):19841-9. PubMed ID: 24860095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prions: generation and spread versus neurotoxicity.
    Halliday M; Radford H; Mallucci GR
    J Biol Chem; 2014 Jul; 289(29):19862-8. PubMed ID: 24860100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How an Infection of Sheep Revealed Prion Mechanisms in Alzheimer's Disease and Other Neurodegenerative Disorders.
    Carlson GA; Prusiner SB
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34064393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of yeast to studying amyloid and prion diseases.
    Chernoff YO; Grizel AV; Rubel AA; Zelinsky AA; Chandramowlishwaran P; Chernova TA
    Adv Genet; 2020; 105():293-380. PubMed ID: 32560789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prions and prion-like proteins.
    Fraser PE
    J Biol Chem; 2014 Jul; 289(29):19839-40. PubMed ID: 24860092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of proteins in neurodegenerative disease].
    Szwed A; Miłowska K
    Postepy Hig Med Dosw (Online); 2012 Apr; 66():187-95. PubMed ID: 22706103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NEURODEGENERATION. Alzheimer's and Parkinson's diseases: The prion concept in relation to assembled Aβ, tau, and α-synuclein.
    Goedert M
    Science; 2015 Aug; 349(6248):1255555. PubMed ID: 26250687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurodegeneration. Could they all be prion diseases?
    Miller G
    Science; 2009 Dec; 326(5958):1337-9. PubMed ID: 19965731
    [No Abstract]   [Full Text] [Related]  

  • 9. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases.
    Jucker M; Walker LC
    Nature; 2013 Sep; 501(7465):45-51. PubMed ID: 24005412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
    Ritchie DL; Barria MA
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33540845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The red-hot debate about transmissible Alzheimer's.
    Abbott A
    Nature; 2016 Mar; 531(7594):294-7. PubMed ID: 26983522
    [No Abstract]   [Full Text] [Related]  

  • 12. Prion-like properties of Tau protein: the importance of extracellular Tau as a therapeutic target.
    Holmes BB; Diamond MI
    J Biol Chem; 2014 Jul; 289(29):19855-61. PubMed ID: 24860099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular Models for the Study of Prions.
    Holmes BB; Diamond MI
    Cold Spring Harb Perspect Med; 2017 Feb; 7(2):. PubMed ID: 27815306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanding spectrum of prion diseases.
    Ayers JI; Paras NA; Prusiner SB
    Emerg Top Life Sci; 2020 Sep; 4(2):155-167. PubMed ID: 32803268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease.
    Wagner J; Ryazanov S; Leonov A; Levin J; Shi S; Schmidt F; Prix C; Pan-Montojo F; Bertsch U; Mitteregger-Kretzschmar G; Geissen M; Eiden M; Leidel F; Hirschberger T; Deeg AA; Krauth JJ; Zinth W; Tavan P; Pilger J; Zweckstetter M; Frank T; Bähr M; Weishaupt JH; Uhr M; Urlaub H; Teichmann U; Samwer M; Bötzel K; Groschup M; Kretzschmar H; Griesinger C; Giese A
    Acta Neuropathol; 2013 Jun; 125(6):795-813. PubMed ID: 23604588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prion-like mechanisms in neurodegenerative diseases.
    Frost B; Diamond MI
    Nat Rev Neurosci; 2010 Mar; 11(3):155-9. PubMed ID: 20029438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prion-like disorders: blurring the divide between transmissibility and infectivity.
    Cushman M; Johnson BS; King OD; Gitler AD; Shorter J
    J Cell Sci; 2010 Apr; 123(Pt 8):1191-201. PubMed ID: 20356930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of crowded physiological environments in prion and prion-like protein aggregation.
    Ma Q; Hu JY; Chen J; Liang Y
    Int J Mol Sci; 2013 Oct; 14(11):21339-52. PubMed ID: 24284393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Conformationally altered proteins cause neurodegenerative diseases].
    Ingelsson M; Nilsson L; Basun H; Aquilonius SM; Lannfelt L
    Lakartidningen; 2005 Nov 21-27; 102(47):3542-3, 3545-6, 3549 passim. PubMed ID: 16408392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases.
    Morales R; Estrada LD; Diaz-Espinoza R; Morales-Scheihing D; Jara MC; Castilla J; Soto C
    J Neurosci; 2010 Mar; 30(13):4528-35. PubMed ID: 20357103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.